On Wednesday, the European Union said that it would get 50 million Pfizer vaccine doses earlier than expected after Denmark banned use of AstraZeneca over blood clot links.
The news broke out after U.S. drugmaker Johnson & Johnson delayed its Covid-19 shot among rising caseloads. Referring to the delay, EU Commission chief Ursula von der Leyen said “there are still many factors that can disrupt the planned delivery schedules of vaccines.”
The EMA said J&J was in contact with national authorities and recommended storing doses already received until the safety committee issued an expedited recommendation, reports Reuters.
Europe will receive BioNTech/Pfizer vaccine doses in the second quarter of this year and the delivery will start as soon as this month.
